Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 709-720 of 1767 results.
"Recent prehospital clinical trials, including the PARAMEDIC-3 trial and VICTOR study, demonstrate no significant difference in 30-day survival between IO and intravenous (IV) access in adult out-of-hospital cardiac arrest (OHCA) patients" Xie and Xiao (2025).
"The '7-Rights Framework for Neonatal VA' emerged through international expert consensus. This framework uses the concept of patient rights, the '7-Rights' - Right Patient, Right Care Team, Right Comfort Measures, Right VA Device, Right Blood Vessel, Right Care of the Infusion and Device, and Right Therapy Duration and Device Removal to integrate best evidence-based practice, ethical considerations, and family involvement" van Rens et al (2025).
"For patients who have an extravasation of an antineoplastic agent, although there is very low certainty in the evidence overall, interventions include administration of an antidote, compress, and surgical referral or escalation of care for extravasation of central lines" DiValerio Gibbs et al (2025).
"Hospital infection prevention and control (IPC) programs are often insufficient to meet the needs of pediatric oncology units (POUs) in low-resource settings. Accordingly, we established partnerships to build and sustain dedicated IPC teams for two POUs in Ecuador and Guatemala" Acebo et al (2025).
"The aim of this retrospective, single-arm study is to assess the clinical outcome of using thrice-weekly teicoplanin (TWT) as outpatient parenteral antibiotic therapy (OPAT) for deep (DSIs) and non-deep-seated infections (NDSIs)" Morena et al (2025).
"A multifaceted approach, including education, empowerment, and effective training, is crucial for successful self-cannulation. By incorporating individualized cannulation technique selection and comprehensive support, care providers can empower patients to adopt self-cannulation and HHD" Bermudez et al (2025).
"Using the example of central line-associated bloodstream infections (CLABSIs), this article demonstrates how the A3's structured approach supports systematic and sustainable process improvement" Yaglowski (2025).
"The author reviews evidence-based strategies for preventing PVAD-related phlebitis and emphasises the need for standardised care protocols and ongoing staff training to support safer PVAD use and reduce the risk of phlebitis" Furtado (2025).
"Although persistent left superior vena cava is a rare anomaly, knowledge of its presence is important for the clinician in order to avoid complications associated with utilizing it for venous access, and to avoid unnecessary replacement for an uncomplicated catheter inserted in it" Heyba et al (2025).
"Together, the six-step instructions, hand model, videos, and trainer feedback provide a complementary training package that can be used to increase cannulation experience, confidence, and success immediately prior to cannulating a patient" Harper et al (2025).
"IV linezolid was frequently associated with early haematological toxicity, amplified by concomitant myelotoxic therapy. Sensitivity and exposure-proxy analyses support the robustness of the signal but highlight residual confounding; prospective studies with exposure monitoring are needed to establish causality" Güneş et al (2025).
"Our study found that peripheral venous catheter use for vasopressor administration in circulatory shock was associated with a low extravasation rate (1.2%), with all events occurring after more than five days, indicating it might be a safe alternative to CVC for short-term use in resource-limited settings" Petros et al (2025).
